[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

VPAResearch: Market Research Reports

VPA Research is one of the global pharmaceutical companies specialized in analysis of clinical trials. We provide leading insights into global Pharma products, pipeline research, companies and drugs markets.

Publications found: 55,654
Sort by:

Constipation pipeline Research Monitor, 2020- Drugs, Companies, Clinical Trials, R&D pipeline updates, status and outlook

US$ 1,599.00

2020 Constipation PIPELINE HIGHLIGHTS Constipation is one of the widely researched conditions during 2020 with 16 companies actively focusing on realizing pipeline’s potential. Development of Constipa...

July 2020 82 pages

Contact Dermatitis pipeline Research Monitor, 2020- Drugs, Companies, Clinical Trials, R&D pipeline updates, status and outlook

US$ 1,599.00

2020 Contact Dermatitis PIPELINE HIGHLIGHTS Contact Dermatitis is one of the widely researched conditions during 2020 with 5 companies actively focusing on realizing pipeline’s potential. Development...

July 2020 40 pages

Contrast Induced Nephropathy pipeline Research Monitor, 2020- Drugs, Companies, Clinical Trials, R&D pipeline updates, status and outlook

US$ 1,599.00

2020 Contrast Induced Nephropathy PIPELINE HIGHLIGHTS Contrast Induced Nephropathy is one of the widely researched conditions during 2020 with 3 companies actively focusing on realizing pipeline’s pot...

July 2020 35 pages

Coronary Artery Disease (CAD) pipeline Research Monitor, 2020- Drugs, Companies, Clinical Trials, R&D pipeline updates, status and outlook

US$ 1,599.00

2020 Coronary Artery Disease (CAD) PIPELINE HIGHLIGHTS Coronary Artery Disease (CAD) is one of the widely researched conditions during 2020 with 39 companies actively focusing on realizing pipeline’s...

July 2020 176 pages

Critical Limb Ischemia pipeline Research Monitor, 2020- Drugs, Companies, Clinical Trials, R&D pipeline updates, status and outlook

US$ 1,599.00

2020 Critical Limb Ischemia PIPELINE HIGHLIGHTS Critical Limb Ischemia is one of the widely researched conditions during 2020 with 27 companies actively focusing on realizing pipeline’s potential. Dev...

July 2020 121 pages

Deep Vein Thrombosis (DVT) pipeline Research Monitor, 2020- Drugs, Companies, Clinical Trials, R&D pipeline updates, status and outlook

US$ 1,599.00

2020 Deep Vein Thrombosis (DVT) PIPELINE HIGHLIGHTS Deep Vein Thrombosis (DVT) is one of the widely researched conditions during 2020 with 6 companies actively focusing on realizing pipeline’s potenti...

July 2020 46 pages

Diabetic Gastroparesis pipeline Research Monitor, 2020- Drugs, Companies, Clinical Trials, R&D pipeline updates, status and outlook

US$ 1,599.00

2020 Diabetic Gastroparesis PIPELINE HIGHLIGHTS Diabetic Gastroparesis is one of the widely researched conditions during 2020 with 10 companies actively focusing on realizing pipeline’s potential. Dev...

July 2020 62 pages

Diarrhea pipeline Research Monitor, 2020- Drugs, Companies, Clinical Trials, R&D pipeline updates, status and outlook

US$ 1,599.00

2020 Diarrhea PIPELINE HIGHLIGHTS Diarrhea is one of the widely researched conditions during 2020 with 29 companies actively focusing on realizing pipeline’s potential. Development of Diarrhea medicin...

July 2020 145 pages

Dilated Cardiomyopathy pipeline Research Monitor, 2020- Drugs, Companies, Clinical Trials, R&D pipeline updates, status and outlook

US$ 1,599.00

2020 Dilated Cardiomyopathy PIPELINE HIGHLIGHTS Dilated Cardiomyopathy is one of the widely researched conditions during 2020 with 9 companies actively focusing on realizing pipeline’s potential. Deve...

July 2020 54 pages

Down Syndrome pipeline Research Monitor, 2020- Drugs, Companies, Clinical Trials, R&D pipeline updates, status and outlook

US$ 1,599.00

2020 Down Syndrome PIPELINE HIGHLIGHTS Down Syndrome is one of the widely researched conditions during 2020 with 13 companies actively focusing on realizing pipeline’s potential. Development of Down S...

July 2020 75 pages

End Stage Kidney Disease (ESRD) pipeline Research Monitor, 2020- Drugs, Companies, Clinical Trials, R&D pipeline updates, status and outlook

US$ 1,599.00

2020 End Stage Kidney Disease (ESRD) PIPELINE HIGHLIGHTS End Stage Kidney Disease (ESRD) is one of the widely researched conditions during 2020 with 8 companies actively focusing on realizing pipeline...

July 2020 52 pages

Enterocolitis pipeline Research Monitor, 2020- Drugs, Companies, Clinical Trials, R&D pipeline updates, status and outlook

US$ 1,599.00

2020 Enterocolitis PIPELINE HIGHLIGHTS Enterocolitis is one of the widely researched conditions during 2020 with 11 companies actively focusing on realizing pipeline’s potential. Development of Entero...

July 2020 60 pages

Eosinophilic Esophagitis (EoE) pipeline Research Monitor, 2020- Drugs, Companies, Clinical Trials, R&D pipeline updates, status and outlook

US$ 1,599.00

2020 Eosinophilic Esophagitis (EoE) PIPELINE HIGHLIGHTS Eosinophilic Esophagitis (EoE) is one of the widely researched conditions during 2020 with 18 companies actively focusing on realizing pipeline’...

July 2020 79 pages

Epidermolysis Bullosa pipeline Research Monitor, 2020- Drugs, Companies, Clinical Trials, R&D pipeline updates, status and outlook

US$ 1,599.00

2020 Epidermolysis Bullosa PIPELINE HIGHLIGHTS Epidermolysis Bullosa is one of the widely researched conditions during 2020 with 33 companies actively focusing on realizing pipeline’s potential. Devel...

July 2020 156 pages

Fanconi Anemia pipeline Research Monitor, 2020- Drugs, Companies, Clinical Trials, R&D pipeline updates, status and outlook

US$ 1,599.00

2020 Fanconi Anemia PIPELINE HIGHLIGHTS Fanconi Anemia is one of the widely researched conditions during 2020 with 6 companies actively focusing on realizing pipeline’s potential. Development of Fanco...

July 2020 50 pages

Functional Dyspepsia (Non Ulcer Dyspepsia) pipeline Research Monitor, 2020- Drugs, Companies, Clinical Trials, R&D pipeline updates, status and outlook

US$ 1,599.00

2020 Functional Dyspepsia (Non Ulcer Dyspepsia) PIPELINE HIGHLIGHTS Functional Dyspepsia (Non Ulcer Dyspepsia) is one of the widely researched conditions during 2020 with 4 companies actively focusing...

July 2020 42 pages

Gastric Ulcers pipeline Research Monitor, 2020- Drugs, Companies, Clinical Trials, R&D pipeline updates, status and outlook

US$ 1,599.00

2020 Gastric Ulcers PIPELINE HIGHLIGHTS Gastric Ulcers is one of the widely researched conditions during 2020 with 6 companies actively focusing on realizing pipeline’s potential. Development of Gastr...

July 2020 42 pages

Gastritis pipeline Research Monitor, 2020- Drugs, Companies, Clinical Trials, R&D pipeline updates, status and outlook

US$ 1,599.00

2020 Gastritis PIPELINE HIGHLIGHTS Gastritis is one of the widely researched conditions during 2020 with 8 companies actively focusing on realizing pipeline’s potential. Development of Gastritis medic...

July 2020 58 pages

Gastroenteritis pipeline Research Monitor, 2020- Drugs, Companies, Clinical Trials, R&D pipeline updates, status and outlook

US$ 1,599.00

2020 Gastroenteritis PIPELINE HIGHLIGHTS Gastroenteritis is one of the widely researched conditions during 2020 with 8 companies actively focusing on realizing pipeline’s potential. Development of Gas...

July 2020 58 pages

Gingivitis pipeline Research Monitor, 2020- Drugs, Companies, Clinical Trials, R&D pipeline updates, status and outlook

US$ 1,599.00

2020 Gingivitis PIPELINE HIGHLIGHTS Gingivitis is one of the widely researched conditions during 2020 with 3 companies actively focusing on realizing pipeline’s potential. Development of Gingivitis me...

July 2020 35 pages

Graves Diseases pipeline Research Monitor, 2020- Drugs, Companies, Clinical Trials, R&D pipeline updates, status and outlook

US$ 1,599.00

2020 Graves Diseases PIPELINE HIGHLIGHTS Graves Diseases is one of the widely researched conditions during 2020 with 9 companies actively focusing on realizing pipeline’s potential. Development of Gra...

July 2020 56 pages

Hepatic Encephalopathy pipeline Research Monitor, 2020- Drugs, Companies, Clinical Trials, R&D pipeline updates, status and outlook

US$ 1,599.00

2020 Hepatic Encephalopathy PIPELINE HIGHLIGHTS Hepatic Encephalopathy is one of the widely researched conditions during 2020 with 12 companies actively focusing on realizing pipeline’s potential. Dev...

July 2020 79 pages

Hidradenitis Suppurativa pipeline Research Monitor, 2020- Drugs, Companies, Clinical Trials, R&D pipeline updates, status and outlook

US$ 1,599.00

2020 Hidradenitis Suppurativa PIPELINE HIGHLIGHTS Hidradenitis Suppurativa is one of the widely researched conditions during 2020 with 19 companies actively focusing on realizing pipeline’s potential....

July 2020 126 pages

Hives (Chronic Urticaria) pipeline Research Monitor, 2020- Drugs, Companies, Clinical Trials, R&D pipeline updates, status and outlook

US$ 1,599.00

2020 Hives (Chronic Urticaria) PIPELINE HIGHLIGHTS Hives (Chronic Urticaria) is one of the widely researched conditions during 2020 with 25 companies actively focusing on realizing pipeline’s potentia...

July 2020 120 pages

Hypereosinophilic Syndrome pipeline Research Monitor, 2020- Drugs, Companies, Clinical Trials, R&D pipeline updates, status and outlook

US$ 1,599.00

2020 Hypereosinophilic Syndrome PIPELINE HIGHLIGHTS Hypereosinophilic Syndrome is one of the widely researched conditions during 2020 with 5 companies actively focusing on realizing pipeline’s potenti...

July 2020 48 pages

Hypertrophic Cardiomyopathy pipeline Research Monitor, 2020- Drugs, Companies, Clinical Trials, R&D pipeline updates, status and outlook

US$ 1,599.00

2020 Hypertrophic Cardiomyopathy PIPELINE HIGHLIGHTS Hypertrophic Cardiomyopathy is one of the widely researched conditions during 2020 with 8 companies actively focusing on realizing pipeline’s poten...

July 2020 52 pages

Hypoparathyroidism pipeline Research Monitor, 2020- Drugs, Companies, Clinical Trials, R&D pipeline updates, status and outlook

US$ 1,599.00

2020 Hypoparathyroidism PIPELINE HIGHLIGHTS Hypoparathyroidism is one of the widely researched conditions during 2020 with 11 companies actively focusing on realizing pipeline’s potential. Development...

July 2020 61 pages

Hypotension pipeline Research Monitor, 2020- Drugs, Companies, Clinical Trials, R&D pipeline updates, status and outlook

US$ 1,599.00

2020 Hypotension PIPELINE HIGHLIGHTS Hypotension is one of the widely researched conditions during 2020 with 6 companies actively focusing on realizing pipeline’s potential. Development of Hypotension...

July 2020 48 pages

Hypothyroidism pipeline Research Monitor, 2020- Drugs, Companies, Clinical Trials, R&D pipeline updates, status and outlook

US$ 1,599.00

2020 Hypothyroidism PIPELINE HIGHLIGHTS Hypothyroidism is one of the widely researched conditions during 2020 with 7 companies actively focusing on realizing pipeline’s potential. Development of Hypot...

July 2020 48 pages

Idiopathic Thrombocytopenic Purpura (ITP) pipeline Research Monitor, 2020- Drugs, Companies, Clinical Trials, R&D pipeline updates, status and outlook

US$ 1,599.00

2020 Idiopathic Thrombocytopenic Purpura (ITP) PIPELINE HIGHLIGHTS Idiopathic Thrombocytopenic Purpura (ITP) is one of the widely researched conditions during 2020 with 23 companies actively focusing...

July 2020 104 pages

Intermittent Claudication pipeline Research Monitor, 2020- Drugs, Companies, Clinical Trials, R&D pipeline updates, status and outlook

US$ 1,599.00

2020 Intermittent Claudication PIPELINE HIGHLIGHTS Intermittent Claudication is one of the widely researched conditions during 2020 with 5 companies actively focusing on realizing pipeline’s potential...

July 2020 42 pages

Interstitial Cystitis (Painful Bladder Syndrome) pipeline Research Monitor, 2020- Drugs, Companies, Clinical Trials, R&D pipeline updates, status and outlook

US$ 1,599.00

2020 Interstitial Cystitis (Painful Bladder Syndrome) PIPELINE HIGHLIGHTS Interstitial Cystitis (Painful Bladder Syndrome) is one of the widely researched conditions during 2020 with 14 companies acti...

July 2020 74 pages

Iron Deficiency Anemia pipeline Research Monitor, 2020- Drugs, Companies, Clinical Trials, R&D pipeline updates, status and outlook

US$ 1,599.00

2020 Iron Deficiency Anemia PIPELINE HIGHLIGHTS Iron Deficiency Anemia is one of the widely researched conditions during 2020 with 13 companies actively focusing on realizing pipeline’s potential. Dev...

July 2020 69 pages

Irritable Bowel Syndrome pipeline Research Monitor, 2020- Drugs, Companies, Clinical Trials, R&D pipeline updates, status and outlook

US$ 1,599.00

2020 Irritable Bowel Syndrome PIPELINE HIGHLIGHTS Irritable Bowel Syndrome is one of the widely researched conditions during 2020 with 34 companies actively focusing on realizing pipeline’s potential....

July 2020 145 pages

Ischemia Reperfusion Injury pipeline Research Monitor, 2020- Drugs, Companies, Clinical Trials, R&D pipeline updates, status and outlook

US$ 1,599.00

2020 Ischemia Reperfusion Injury PIPELINE HIGHLIGHTS Ischemia Reperfusion Injury is one of the widely researched conditions during 2020 with 38 companies actively focusing on realizing pipeline’s pote...

July 2020 170 pages

Ischemic Heart Disease pipeline Research Monitor, 2020- Drugs, Companies, Clinical Trials, R&D pipeline updates, status and outlook

US$ 1,599.00

2020 Ischemic Heart Disease PIPELINE HIGHLIGHTS Ischemic Heart Disease is one of the widely researched conditions during 2020 with 39 companies actively focusing on realizing pipeline’s potential. Dev...

July 2020 176 pages

Keloids pipeline Research Monitor, 2020- Drugs, Companies, Clinical Trials, R&D pipeline updates, status and outlook

US$ 1,599.00

2020 Keloids PIPELINE HIGHLIGHTS Keloids is one of the widely researched conditions during 2020 with 8 companies actively focusing on realizing pipeline’s potential. Development of Keloids medicines i...

July 2020 53 pages

Kidney Fibrosis pipeline Research Monitor, 2020- Drugs, Companies, Clinical Trials, R&D pipeline updates, status and outlook

US$ 1,599.00

2020 Kidney Fibrosis PIPELINE HIGHLIGHTS Kidney Fibrosis is one of the widely researched conditions during 2020 with 32 companies actively focusing on realizing pipeline’s potential. Development of Ki...

July 2020 132 pages

Left Ventricular Dysfunction pipeline Research Monitor, 2020- Drugs, Companies, Clinical Trials, R&D pipeline updates, status and outlook

US$ 1,599.00

2020 Left Ventricular Dysfunction PIPELINE HIGHLIGHTS Left Ventricular Dysfunction is one of the widely researched conditions during 2020 with 6 companies actively focusing on realizing pipeline’s pot...

July 2020 42 pages

Liver Cirrhosis pipeline Research Monitor, 2020- Drugs, Companies, Clinical Trials, R&D pipeline updates, status and outlook

US$ 1,599.00

2020 Liver Cirrhosis PIPELINE HIGHLIGHTS Liver Cirrhosis is one of the widely researched conditions during 2020 with 26 companies actively focusing on realizing pipeline’s potential. Development of Li...

July 2020 126 pages

Liver Failure pipeline Research Monitor, 2020- Drugs, Companies, Clinical Trials, R&D pipeline updates, status and outlook

US$ 1,599.00

2020 Liver Failure PIPELINE HIGHLIGHTS Liver Failure is one of the widely researched conditions during 2020 with 23 companies actively focusing on realizing pipeline’s potential. Development of Liver...

July 2020 112 pages

Meniere Disease pipeline Research Monitor, 2020- Drugs, Companies, Clinical Trials, R&D pipeline updates, status and outlook

US$ 1,599.00

2020 Meniere Disease PIPELINE HIGHLIGHTS Meniere Disease is one of the widely researched conditions during 2020 with 6 companies actively focusing on realizing pipeline’s potential. Development of Men...

July 2020 45 pages

Myocardial Fibrosis pipeline Research Monitor, 2020- Drugs, Companies, Clinical Trials, R&D pipeline updates, status and outlook

US$ 1,599.00

2020 Myocardial Fibrosis PIPELINE HIGHLIGHTS Myocardial Fibrosis is one of the widely researched conditions during 2020 with 14 companies actively focusing on realizing pipeline’s potential. Developme...

July 2020 71 pages

Myocardial Ischemia pipeline Research Monitor, 2020- Drugs, Companies, Clinical Trials, R&D pipeline updates, status and outlook

US$ 1,599.00

2020 Myocardial Ischemia PIPELINE HIGHLIGHTS Myocardial Ischemia is one of the widely researched conditions during 2020 with 11 companies actively focusing on realizing pipeline’s potential. Developme...

July 2020 61 pages

Myocarditis pipeline Research Monitor, 2020- Drugs, Companies, Clinical Trials, R&D pipeline updates, status and outlook

US$ 1,599.00

2020 Myocarditis PIPELINE HIGHLIGHTS Myocarditis is one of the widely researched conditions during 2020 with 5 companies actively focusing on realizing pipeline’s potential. Development of Myocarditis...

July 2020 40 pages

Nasal Polyps pipeline Research Monitor, 2020- Drugs, Companies, Clinical Trials, R&D pipeline updates, status and outlook

US$ 1,599.00

2020 Nasal Polyps PIPELINE HIGHLIGHTS Nasal Polyps is one of the widely researched conditions during 2020 with 9 companies actively focusing on realizing pipeline’s potential. Development of Nasal Pol...

July 2020 54 pages

Nasopharyngitis (Common Cold) pipeline Research Monitor, 2020- Drugs, Companies, Clinical Trials, R&D pipeline updates, status and outlook

US$ 1,599.00

2020 Nasopharyngitis (Common Cold) PIPELINE HIGHLIGHTS Nasopharyngitis (Common Cold) is one of the widely researched conditions during 2020 with 7 companies actively focusing on realizing pipeline’s p...

July 2020 50 pages

Nephrotic Syndrome pipeline Research Monitor, 2020- Drugs, Companies, Clinical Trials, R&D pipeline updates, status and outlook

US$ 1,599.00

2020 Nephrotic Syndrome PIPELINE HIGHLIGHTS Nephrotic Syndrome is one of the widely researched conditions during 2020 with 5 companies actively focusing on realizing pipeline’s potential. Development...

July 2020 52 pages

Neutropenia pipeline Research Monitor, 2020- Drugs, Companies, Clinical Trials, R&D pipeline updates, status and outlook

US$ 1,599.00

2020 Neutropenia PIPELINE HIGHLIGHTS Neutropenia is one of the widely researched conditions during 2020 with 24 companies actively focusing on realizing pipeline’s potential. Development of Neutropeni...

July 2020 118 pages

Nocturia pipeline Research Monitor, 2020- Drugs, Companies, Clinical Trials, R&D pipeline updates, status and outlook

US$ 1,599.00

2020 Nocturia PIPELINE HIGHLIGHTS Nocturia is one of the widely researched conditions during 2020 with 5 companies actively focusing on realizing pipeline’s potential. Development of Nocturia medicine...

July 2020 45 pages

Filters

Search

Categories

12,968
1,223
4,429
2
1
8,271
2,818
15,138
67
8,921
1
1,229
586

Publishers

55,654

Regions

1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
55,617

Price

Date

Pages

Offers